| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038063 |
| Receipt No. | R000043388 |
| Scientific Title | Investigation of the Etiology in Retinal Pigment Epithelium of Macular Diseases |
| Date of disclosure of the study information | 2020/07/10 |
| Last modified on | 2021/02/17 (Ver. 6) |
| Basic information | ||
| Public title | Investigation of the Etiology of Eye Diseases | |
| Acronym | Investigation of the Eye Diseases | |
| Scientific Title | Investigation of the Etiology in Retinal Pigment Epithelium of Macular Diseases | |
| Scientific Title:Acronym | Investigation of the Macular Diseases | |
| Region |
|
|
| Condition | ||
| Condition | Macular diseases | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In this study, we clarify that the retinal pigment epithelium disorder of macular area using short- and long-wavelength autofluorescence, and optical coherence tomography. |
| Basic objectives2 | Others |
| Basic objectives -Others | Serous retinal detachment, bleeding, Bruch's membrane deposit |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Degree of abnormality of retinal pigment epithelium |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients who visited the university facility for examination for macular disease during the period were eligible for this study.If patient consent is obtained, they will be enrolled in this study. | |||
| Key exclusion criteria | Patients with iodine allergy or fluorescein allergy. Patients who have not obtained consent for this study. | |||
| Target sample size | 72 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University School of Medicine | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku | ||||||
| TEL | +81-3-5363-3204 | ||||||
| ari.shinojima@keio.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University School of Medicine | ||||||
| Division name | Department of Ophthalmology | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku | ||||||
| TEL | +81-3-5363-3204 | ||||||
| Homepage URL | |||||||
| ari.shinojima@keio.jp | |||||||
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | JSPS |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Keio University School of Medicine |
| Address | 35 Shinanomachi, Shinjuku-ku |
| Tel | +81-3-5363-3204 |
| ari.shinojima@keio.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 22 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Observational Study
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043388 |